| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Canadian Journal of Anesthesia, Vol 41, 502-512, Copyright © 1994 by Canadian Anesthesiologists' Society
ARTICLES |
KG Smedstad, R Cramb and DH Morison
Department of Anaesthesia, McMaster University, Hamilton, Ontario.
This is the report of a series of eight patients with pulmonary hypertension (primary and secondary) who delivered at the McMaster University Medical Centre between 1978 and 1987. Seven of the eight patients delivered vaginally and had a successful outcome. The eighth patient was admitted as an emergency and died shortly after Caesarean section under general anaesthesia, performed to save the infant. The other seven patients were all managed by a team, including anaesthetists, cardiologists and obstetricians, from about 25 wk. The patients were hospitalized pre-partum and received oxygen therapy and anticoagulation with heparin. Analgesia in labour was managed, once anticoagulation was reversed, by low concentrations of epidural bupivacaine (0.125%-0.375%) and fentanyl. The patients were monitored during labour and delivery with oximetry and arterial and central venous pressure lines. Pulmonary arterial lines were not used because of increased risk and questionable usefulness. Vaginal delivery was managed with vacuum extraction or forceps lift-out to minimize the stress of pushing. After delivery, all patients were monitored in an intensive care unit for several days, anticoagulation was restarted, and all patients were discharged home taking oral anticoagulant therapy. The successful management of pulmonary hypertension in pregnancy should include team management started early in pregnancy and controlled vaginal delivery utilizing epidural analgesia.
This article has been cited by other articles:
![]() |
National Pulmonary Hypertension Centres of the UK Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland Heart, March 1, 2008; 94(Suppl_1): i1 - i41. [Full Text] [PDF] |
||||
![]() |
National Pulmonary Hypertension Centres of the UK Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland Thorax, March 1, 2008; 63(Suppl_2): ii1 - ii41. [Full Text] [PDF] |
||||
![]() |
W. Drenthen, P. G. Pieper, J. W. Roos-Hesselink, W. A. van Lottum, A. A. Voors, B. J.M. Mulder, A. P.J. van Dijk, H. W. Vliegen, S. C. Yap, P. Moons, et al. Outcome of Pregnancy in Women With Congenital Heart Disease: A Literature Review J. Am. Coll. Cardiol., June 19, 2007; 49(24): 2303 - 2311. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. George, A. J. Olufolabi, and H. A. Muir Critical arrhythmia associated with pulmonary artery catheterization in a parturient with severe pulmonary hypertension Can J Anesth, June 1, 2007; 54(6): 486 - 487. [Full Text] [PDF] |
||||
![]() |
P. Ray, G. J. Murphy, and L. E. Shutt Recognition and management of maternal cardiac disease in pregnancy Br. J. Anaesth., September 1, 2004; 93(3): 428 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Lovell Anaesthetic implications of grown-up congenital heart disease Br. J. Anaesth., July 1, 2004; 93(1): 129 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Badesch, S. H. Abman, G. S. Ahearn, R. J. Barst, D. C. McCrory, G. Simonneau, and V. V. McLaughlin Medical Therapy For Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines Chest, July 1, 2004; 126(1_suppl): 35S - 62S. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Bildirici and J B. Shumway Intravenous and Inhaled Epoprostenol for Primary Pulmonary Hypertension During Pregnancy and Delivery Obstet. Gynecol., May 1, 2004; 103(5): 1102 - 1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Lacassie, A. M. Germain, G. Valdes, M S. Fernandez, F. Allamand, and H. Lopez Management of Eisenmenger Syndrome in Pregnancy With Sildenafil and l-arginine Obstet. Gynecol., May 1, 2004; 103(5): 1118 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Mcmillan, W L Martin, J Waugh, I Rushton, M Lewis, T Clutton-Brock, J N Townend, M D Kilby, and C Gordon Management of pregnancy in women with pulmonary hypertension secondary to SLE and anti-phospholipid syndrome Lupus, June 1, 2002; 11(6): 392 - 398. [Abstract] [PDF] |
||||
![]() |
G. K. Lam, R. E. Stafford, J. Thorp, K. J. Moise Jr, and B. A. Cairns Inhaled Nitric Oxide for Primary Pulmonary Hypertension in Pregnancy Obstet. Gynecol., November 1, 2001; 98(5): 895 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Monnery, J. Nanson, and G. Charlton Primary pulmonary hypertension in pregnancy; a role for novel vasodilators Br. J. Anaesth., August 1, 2001; 87(2): 295 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Decoene, K. Bourzoufi, D. Moreau, F. Narducci, F. Crepin, and R. Krivosic-Horber Use of inhaled nitric oxide for emergency Cesarean section in a woman with unexpected primary pulmonary hypertension : [L'inhalation d'oxyde nitrique pour la cesarienne d'urgence associee a une hypertension pulmonaire primitive inattendue] Can J Anesth, June 1, 2001; 48(6): 584 - 587. [Abstract] [Full Text] |
||||
![]() |
R. Stewart, D. Tuazon, G. Olson, and A. G. Duarte Pregnancy and Primary Pulmonary Hypertension : Successful Outcome With Epoprostenol Therapy Chest, March 1, 2001; 119(3): 973 - 975. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.M Weiss and O.M Hess Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives Eur. Heart J., January 2, 2000; 21(2): 104 - 115. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |